Related references
Note: Only part of the references are listed.Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
Laura Basso et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support
Denise Beaudequin et al.
BMC PSYCHIATRY (2020)
Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder
Virginie Sterpenich et al.
ANESTHESIOLOGY (2019)
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
Oloruntoba J. Oluboka et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Potential of Bayesian networks for adaptive management in water recycling
Denise Beaudequin et al.
ENVIRONMENTAL MODELLING & SOFTWARE (2017)
Understanding the Impairment Associated With Depressive Symptoms
Bjorn Hanson et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2017)
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant
Elizabeth D. Ballard et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
The WHO-5 Well-Being Index: A Systematic Review of the Literature
Christian Winther Topp et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
Lael Reinstatler et al.
DRUGS IN R&D (2015)
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Mark J. Niciu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
The psychology of suicidal behaviour
Rory C. O'Connor et al.
LANCET PSYCHIATRY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS
Roger S. McIntyre et al.
DEPRESSION AND ANXIETY (2013)
Risk factors for suicide in individuals with depression: A systematic review
Keith Hawton et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?
Mark Zimmerman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Quality of Life: The Ultimate Outcome Measure of Interventions in Major Depressive Disorder
Waguih William IsHak et al.
HARVARD REVIEW OF PSYCHIATRY (2011)
Comorbidity: A network perspective
Angelique O. J. Cramer et al.
BEHAVIORAL AND BRAIN SCIENCES (2010)
Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study
I. Romera et al.
EUROPEAN PSYCHIATRY (2010)
Subjective Wellbeing, Homeostatically Protected Mood and Depression: A Synthesis
Robert A. Cummins
JOURNAL OF HAPPINESS STUDIES (2010)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
The importance of functional impairment to mental health outcomes: A case for reassessing our goals in depression treatment research
Patrick E. McKnight et al.
CLINICAL PSYCHOLOGY REVIEW (2009)
Subjective psychological well-being (WHO-5) in assessment of the severity of suicide attempt
Merike Sisask et al.
NORDIC JOURNAL OF PSYCHIATRY (2008)
Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residents
S. Awata et al.
INTERNATIONAL PSYCHOGERIATRICS (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Quality-of-life impairment in depressive and anxiety disorders
MH Rapaport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Share Paper
